Clearfield, Inc.
CLFD Nasdaq Telephone & Telegraph Apparatus Financials FY2016βFY2025
What Clearfield, Inc. does
No business description yet.
- Legal name
- Clearfield, Inc.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K Β· Nov 25, 2025
- Accession Β· CIK
- 0001171843-25-007594
0000796505
Revenue and margins
Clearfield, Inc. had $150M of revenue in fiscal 2025, up 19.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $21.8M in fiscal 2025, 14.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Clearfield, Inc. returned $16.7M to shareholders in fiscal 2025, 76% of free cash flow. The diluted share count fell 4.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Clearfield, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $23.6M | $22.5M | $168M | $129M | $106M |
| Debt incl. finance leases | $0.0M | $18.7M | $2.1M | $2.2M | β |
| Net debt / EBITDA | β0.9x | β0.1x | β3.9x | β | β |
| Debt / equity | 0.0x | 0.1x | 0.0x | 0.0x | β |
| Interest coverage | β | 205.2x | 42.7x | β38.0x | β |
| Current ratio | 3.5x | 3.1x | 10.2x | 9.4x | 5.4x |
| Quick ratio | 2.1x | 1.5x | 6.8x | 7.1x | 4.3x |
| Total assets | $126M | $229M | $356M | $315M | $306M |
| Total liabilities | $22.1M | $81.5M | $40.4M | $39.5M | $50.0M |
| Shareholders' equity | $104M | $148M | $315M | $276M | $256M |
| Net debt (β = net cash) | β$23.6M | β$3.8M | β$166M | β$127M | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 5 / 8 | 4 / 8 | 4 / 8 | 5 / 8 | 4 / 9 | 4 / 9 | 3 / 9 | 6 / 8 |
| Accruals ratio | β5.0% | β3.5% | β0.4% | β13.0% | 0.7% | 8.5% | 26.5% | 4.8% | β10.3% | β11.1% |
| Altman Z'' | 13.54 | 18.05 | 17.74 | 15.32 | 11.28 | 10.12 | 8.23 | 15.01 | 12.38 | 10.03 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $75.3M | $73.9M | $77.7M | $85.0M | $93.1M | $141M | $271M | $226M | $126M | $150M |
| Gross profit | $32.9M | $30.3M | $31.0M | $32.7M | $37.9M | $61.2M | $113M | $79.9M | $25.8M | $50.5M |
| Research and development | $0.8M | $0.9M | $0.8M | $1.1M | $1.3M | $0.2M | $0.9M | $3.1M | $3.0M | $2.4M |
| Operating income | $10.7M | $5.3M | $5.1M | $5.2M | $8.4M | $25.2M | $63.8M | $37.6M | β$19.2M | $2.1M |
| Interest expense | β | β | β | β | β | β | $0.3M | $0.9M | $0.5M | β |
| Pretax income | $10.9M | $5.6M | $5.5M | $5.9M | $9.2M | $25.7M | $63.8M | $42.6M | β$11.8M | $8.7M |
| Income tax | $2.9M | $1.7M | $1.3M | $1.4M | $1.9M | $5.4M | $14.5M | $8.9M | β$3.2M | $2.4M |
| Net income | $8.0M | $3.8M | $4.3M | $4.6M | $7.3M | $20.3M | $49.4M | $32.5M | β$12.5M | β$8.1M |
| Diluted EPS | $0.59 | $0.28 | $0.32 | $0.34 | $0.53 | $1.47 | $3.55 | $2.17 | β$0.85 | β$0.58 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.02B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $11.6M | $6.3M | $4.5M | $14.7M | $6.7M | $10.9M | $2.3M | $18.4M | $22.2M | $26.6M |
| Capital expenditure | $1.6M | $2.0M | $1.2M | $2.5M | $1.8M | $2.0M | $8.5M | $7.7M | $9.6M | $4.7M |
| Free cash flow | $10.0M | $4.3M | $3.4M | $12.2M | $4.8M | $8.9M | β$6.2M | $10.7M | $12.7M | $21.8M |
| Depreciation and amortization | $1.4M | $1.6M | $2.0M | $2.2M | $2.4M | $2.3M | $3.4M | $4.6M | $5.9M | $6.1M |
| Stock-based compensation | $1.4M | $2.3M | $2.0M | $1.7M | $0.8M | $1.3M | $2.3M | $3.6M | $4.4M | $4.6M |
| Acquisitions | β | β | β | β | $0.0M | $0.0M | $16.2M | $0.0M | $0.0M | β |
| Share buybacks | $0.3M | $3.6M | $1.8M | β | $0.4M | $0.0M | $0.0M | $0.0M | $33.4M | $16.7M |
| Dividends and buybacks | $0.3M | $3.6M | $1.8M | β | $0.4M | $0.0M | $0.0M | $0.0M | $33.4M | $16.7M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $33.5M | $24.5M | $17.5M | $23.6M | $27.0M | $23.6M | $22.5M | $168M | $129M | $106M |
| Total debt | β | β | β | β | β | $0.0M | $18.7M | $2.1M | $2.2M | β |
| Current assets | $51.1M | $41.1M | $41.1M | $42.5M | $52.5M | $71.5M | $160M | $296M | $230M | $198M |
| Current liabilities | $7.3M | $4.2M | $5.0M | $6.6M | $10.4M | $20.5M | $51.7M | $29.0M | $24.4M | $36.6M |
| Inventory | $8.4M | $8.5M | $10.1M | $9.0M | $14.4M | $27.5M | $82.2M | $98.1M | $56.1M | $42.0M |
| Property and equipment, net | $5.8M | $5.4M | $4.7M | $5.4M | $5.0M | $5.0M | $18.2M | $21.5M | $15.9M | $9.7M |
| Goodwill | $2.6M | $2.6M | $4.7M | $4.7M | $4.7M | $4.7M | $6.4M | $6.5M | $6.6M | $4.7M |
| Intangible assets | β | $0.3M | $5.5M | $5.1M | $5.0M | $4.7M | $6.4M | $6.1M | $4.7M | $9.4M |
| Total assets | $70.6M | $69.5M | $74.2M | $81.9M | $95.3M | $126M | $229M | $356M | $315M | $306M |
| Total liabilities | $8.0M | $5.0M | $5.4M | $7.0M | $12.5M | $22.1M | $81.5M | $40.4M | $39.5M | $50.0M |
| Preferred stock | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $62.6M | $64.5M | $68.9M | $74.9M | $82.8M | $104M | $148M | $315M | $276M | $256M |
| Margins | ||||||||||
| Gross margin | 43.7% | 40.9% | 39.9% | 38.4% | 40.7% | 43.5% | 41.7% | 35.4% | 20.6% | 33.7% |
| Operating margin | 14.3% | 7.2% | 6.5% | 6.1% | 9.0% | 17.9% | 23.6% | 16.6% | β15.3% | 1.4% |
| EBITDA margin | 16.2% | 9.4% | 9.2% | 8.7% | 11.6% | 19.6% | 24.8% | 18.7% | β10.6% | 5.5% |
| Net margin | 10.6% | 5.2% | 5.5% | 5.4% | 7.8% | 14.4% | 18.2% | 14.4% | β9.9% | β5.4% |
| FCF margin | 13.3% | 5.8% | 4.3% | 14.4% | 5.2% | 6.3% | β2.3% | 4.8% | 10.1% | 14.5% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | 24.8% | 34.3% | 19.9% | β10.2% | β |
| Return on capital employed | 17.0% | 8.1% | 7.3% | 6.9% | 9.9% | 23.9% | 36.0% | 11.5% | β6.6% | 0.8% |
| Return on equity | 12.8% | 6.1% | 6.4% | 6.4% | 9.3% | 21.8% | 39.3% | 14.1% | β4.2% | β3.0% |
| Return on assets | 11.4% | 5.5% | 5.9% | 5.8% | 8.2% | 18.4% | 27.8% | 11.1% | β3.7% | β2.6% |
| Return on tangible equity | 13.3% | 6.2% | 7.3% | 7.0% | 10.0% | 21.5% | 36.6% | 10.8% | β4.7% | β3.3% |
| Growth | ||||||||||
| Revenue growth | β | β1.8% | 5.0% | 9.5% | 9.5% | 51.2% | 92.5% | β16.7% | β44.4% | 19.6% |
| Net income growth | β | β52.0% | 11.1% | 6.8% | 59.7% | 178.7% | 142.8% | β34.1% | β138.3% | β |
| EPS growth | β | β52.5% | 14.3% | 6.3% | 55.9% | 177.4% | 141.5% | β38.9% | β139.2% | β |
| FCF growth | β | β57.2% | β21.5% | 264.0% | β60.3% | 82.6% | β170.5% | β | 17.8% | 72.3% |
| Share count change | β | β0.0% | β1.5% | β0.0% | 1.4% | 1.0% | 0.9% | 8.0% | β2.9% | β4.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β0.9x | β0.1x | β3.9x | β | β |
| Debt / equity | β | β | β | β | β | 0.0x | 0.1x | 0.0x | 0.0x | β |
| Interest coverage | β | β | β | β | β | β | 205.2x | 42.7x | β38.0x | β |
| Current ratio | 7.0x | 9.7x | 8.3x | 6.4x | 5.0x | 3.5x | 3.1x | 10.2x | 9.4x | 5.4x |
| Quick ratio | 5.8x | 7.7x | 6.2x | 5.1x | 3.7x | 2.1x | 1.5x | 6.8x | 7.1x | 4.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.1% | 2.7% | 1.5% | 3.0% | 1.9% | 1.5% | 3.1% | 3.4% | 7.6% | 3.2% |
| Stock comp / revenue | 1.9% | 3.1% | 2.6% | 2.0% | 0.8% | 0.9% | 0.9% | 1.6% | 3.5% | 3.1% |
| Payouts / FCF | 3.3% | 85.3% | 52.4% | β | 8.8% | 0.0% | β | 0.0% | 263.7% | 76.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 5.0 | 4.0 | 4.0 | 5.0 | 4.0 | 4.0 | 3.0 | 6.0 |
| Altman Z'' | 13.5 | 18.1 | 17.7 | 15.3 | 11.3 | 10.1 | 8.2 | 15.0 | 12.4 | 10.0 |
| Accruals ratio | β5.0% | β3.5% | β0.4% | β13.0% | 0.7% | 8.5% | 26.5% | 4.8% | β10.3% | β11.1% |
Source: SEC EDGAR XBRL filings (CIK 0000796505). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.